EGFR Exon 19 Insertions: A New Family of Sensitizing EGFR Mutations in Lung Adenocarcinoma

Eitemau Tebyg

• EGFR Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics
  gan: Arcila, Maria E, et al.
  Cyhoeddwyd: (2013)
• EGFR exon 20 insertions in advanced lung adenocarcinomas: clinical outcomes and response to erlotinib
  gan: Naidoo, J, et al.
  Cyhoeddwyd: (2015)
• Response heterogeneity of EGFR and HER2 exon 20 insertions to covalent EGFR and HER2 inhibitors
  gan: Kosaka, Takayuki, et al.
  Cyhoeddwyd: (2017)
• Natural history and molecular characteristics of lung cancers harboring EGFR exon 20 insertions
  gan: Oxnard, Geoffrey R., et al.
  Cyhoeddwyd: (2013)
• Response to standard therapies and comprehensive genomic analysis for patients with lung adenocarcinoma with EGFR exon 20 insertions
  gan: Choudhury, Noura J., et al.
  Cyhoeddwyd: (2021)